<DOC>
	<DOCNO>NCT02412085</DOCNO>
	<brief_summary>This open-label , phase IV trial . Adult patient , moderately severe , steroid dependent , acute ulcerative colitis previously expose anti-TNF , receive subcutaneous golimumab treatment , accord EU marketing authorization baseline week 14 . At week 16 , patient achieve clinical endoscopic remission continue Golimumab , 50 mg 100 mg ( depend body weight ) every 4 week , week 52 . Patients achieve clinical endoscopic remission treat infliximab , accord marketing authorization , follow week 52 . This consider interventional arm , since infliximab Italy consider first-line treatment UC patient , usual clinical practice .</brief_summary>
	<brief_title>Golimumab Steroid-dependent Ulcerative Colitis : Induction Maintenance Clinical Endoscopic Remission</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>patient age 1865 year ability understand study procedure sign inform consent ulcerative colitis diagnose least 6 month previous exposure antiTNFs Global Mayo score ≥ 6 ( endoscopic subscore ≥2 ) baseline steroiddependent disease woman childbearing potential must accept effective contraception study participation leas 6 month end study participation Crohn 's disease undetermined colitis active infection previous infection completely resolve baseline malignancy previous 5 year suspect latent tuberculosis infection every potentially harmful clinical condition , opinion investigator patient moderately severe heart failure ( NYHA class III/IV ) hepatic renal failure pregnant lactating woman woman plan pregnancy baseline 3 month study completion permit concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>golimumab</keyword>
	<keyword>ulcerative colitis</keyword>
	<keyword>steroid-dependent</keyword>
</DOC>